1154695

Sophie Piperno-Neumann — FEI 3019825045

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 17, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Paris (France)

Additional Details

Clinical Investigator (CI)